2013 Analysis of biomarkers in circulating tumor DNA from the phase 3 CONCUR study of regorafenib in Asian patients with metastatic colorectal cancer (mCRC): Correlation with clinical outcome. (September 2015) - Teufel, M.; Kalmus, J.; Rutstein, M.; Köchert, K.; Seidel, H.; Reischl, J.; Skubula, A.; Vonk, R.; Wilhelm, S.; Kobina, S.; Qin, S.; Xu, R.; et al.